Mercy Hospital & Health Services Contact Us
MyChart
About Mercy
Join Our Team
set font size large set font size medium set font size small
email this page print this page
Health Illustrated Encyclopedia Banner
Health Illustrated Encyclopedia

Disclaimer:
Our Health Information Database is provided by A.D.A.M. the leading provider of electronic and printed information for professionals and consumers in healthcare and industry. It provides authoritative, reliable content written and reviewed by an editorial board who represent a variety of specialty areas. This board reviews and evaluates all healthcare information to ensure it is accurate, reliable, and can be used with complete confidence. And now you have access to the same authoritative, trusted clinical information relied upon by health professionals around the world.
Von Willebrand disease

Definition

Von Willebrand disease is the most common hereditary bleeding disorder.

Alternative Names

Causes, incidence, and risk factors

Von Willebrand disease is caused by a deficiency of von Willebrand factor. Von Willebrand factor helps blood platelets clump together and stick to the blood vessel wall, which is necessary for normal blood clotting. There are several types of Von Willebrand disease.

Von Willebrand disease affects men and women equally. Most cases are mild. Bleeding may occur after surgery or when you have a tooth pulled. Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) can make this condition worse. Bleeding may decrease during pregnancy.

A family history of a bleeding disorder is the primary risk factor. In women with heavy or prolonged menstrual bleeding, von Willebrand is more common in Caucasian women than in African American women. The majority of women with heavy or prolonged menstrual bleeding do NOT have Von Willebrand disease.

Symptoms

Signs and tests

Tests that may be done to diagnose this disease include:

This disease may also alter the results of the following tests:

  • Factor VIII level
  • Von Willebrand factor multimers (parts of the von Willebrand factor protein molecule)

Von Willebrand disease may be hard to diagnose. Low von Willebrand factor levels and bleeding do not always mean you have von Willebrand disease.

Treatment

Medications such as desamino-8-arginine vasopressin (DDAVP) can be given to raise the levels of von Willebrand factor, which will reduce the tendency toward bleeding.

Some types of von Willebrand disease do not respond to DDAVP. Tests should be done to determine a patient's specific type of von Willebrand disease before trauma or surgery occurs. A trial of DDAVP can be done before surgery to test whether von Willebrand factor levels increase.

The drug Alphanate (antihemophilic factor) is approved to decrease bleeding in patients with the disease who must have surgery or any other invasive procedure.

Blood plasma or certain factor VIII preparations may also be used to decrease bleeding.

Support Groups

Expectations (prognosis)

Women who have this condition generally do NOT have excessive bleeding during childbirth.

This disease is passed down through families. Therefore, genetic counseling may help prospective parents understand the risk to their children.

Complications

Bleeding (hemorrhaging) may occur after surgeries or other invasive procedures.

If you have von Willebrand disease, do not take nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin or ibuprofen, without talking to your health care provider.

Calling your health care provider

Call your health care provider if bleeding occurs without reason.

If you have von Willebrand disease and are scheduled for surgery or are in an accident, be sure you or your family notify the health care providers about your condition.

Prevention

References

Kessler CM. Hemorrhagic disorders: coagulation factor deficiencies. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 180.

View Spanish Version

Encyclopedia Home
Drug Note Home
Health Information Home

Images

Care Points
    Read More

    Review Date: 3/28/2010

    Review By: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

    The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2010 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

    www.adam.com
    www.mercyweb.org
    follow us online
    facebook youtube


    Contact us
    Home  |  Sitemap

    Disclaimer & Terms of Use  |  Privacy Statement  |  Notice of Privacy Practices
    Copyright ©2013 Mercy. Last modified 2/16/2011